Article
Symplekin specifies mitotic fidelity by supporting microtubule dynamics.
Molecular and cellular biology - 1 Nov 2010
Cappell Kathryn M, Larson Brittany, Sciaky Noah, Whitehurst Angelique W
Abstract excerpt
Using a pangenomic loss-of-function screening strategy, we have previously identified 76 potent modulators of paclitaxel responsiveness in non-small-cell lung cancer. The top hit isolated from this screen, symplekin, is a well-established component of the mRNA polyadenylation machinery. Here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
